While a single 5-mg dose pharmacokinetic study cannot provide long-term data, results from phase III studies consistently showed decreases in mean alanine transaminase and aspartate transaminase values in people with T2D treated with tirzepatide (mean percent changes from baseline ranged from 12 to 33% for alanine transaminase and 1 to 16% for aspartate transaminase) [9,10,11,12,13]
You're told to rest, go to physical therapy, get injections, and if all else fails, consider surgery
Well review your history and goals, explain your options, and recommend an approach that fits
What are B12 Injections used for
Rotating injection sites with each dose helps reduce skin irritation and supports consistent medication absorption